Drug Discovery Today

雜志介紹

Drug Discovery Today雜志介紹

《Drug Discovery Today》是一本以English為主的未開放獲取國際優秀期刊，中文名稱今天的藥物發現，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為6.5，最新CiteScore 指數為14.8。

本刊近期中國學者發表的論文主要有：

• Medicinal chemistry insights into antiviral peptidomimetics

  Author: Ding, Dang; Xu, Shujing; da Silva-Junior, Edeildo Ferreira; Liu, Xinyong; Zhan, Peng

• Therapeutic potential of fucosyltransferases in cancer and recent development of targeted inhibitors

  Author: Lv, Yixin; Zhang, Zhoudong; Tian, Sheng; Wang, Weipeng; Li, Huanqiu

• The transmembrane domains of GPCR dimers as targets for drug development

  Author: Cai, Xin; Wang, Dexiu; Zhang, Rumin; Chen, Yanchun; Chen, Jing

• Cordycepin and kinase inhibition in cancer

  Author: Khan, Md Asaduzzaman; Tania, Mousumi

英文介紹

Drug Discovery Today雜志英文介紹

Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.

Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.

Coverage includes:

? Novel therapeutic strategies

? High-throughput screening

? Therapeutic targets

? Combinatorial chemistry, parallel synthesis and library design

? Drug delivery

? ADME/Tox

? Advances in key compound classes and therapeutic areas

? Genomics and proteomics

? Automation and technology

? Virtual chemistry

? Informatics

? Business strategy

? Clinical trials

and other aspects of drug discovery.